- Q1 2024 Y-mAbs Therapeutics Inc Earnings Call TranscriptMay 08, 2024$13.61 (-20.92%)Earnings
- Q4 2023 Y-mAbs Therapeutics Inc Earnings Call TranscriptMar 01, 2024$18.69 (+11.92%)Earnings
- Y-mAbs Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2024
- Q3 2023 Y-mAbs Therapeutics Inc Earnings Call TranscriptNov 14, 2023$5.36 (+9.84%)Earnings
- Q2 2023 Y-mAbs Therapeutics Inc Earnings Call TranscriptAug 11, 2023$5.55 (-9.90%)Earnings
- Q1 2023 Y-mAbs Therapeutics Inc Earnings Call TranscriptMay 09, 2023$9.23 (+36.34%)Earnings
- Q4 2022 Y-mAbs Therapeutics Inc Earnings Call TranscriptMar 31, 2023$5.01 (+52.28%)Earnings
- Y-mAbs Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2023
- Y-mAbs Therapeutics Inc To Host Annual Research and Development Day TranscriptDec 14, 2022
- Q3 2022 Y-mAbs Therapeutics Inc Earnings Call TranscriptNov 08, 2022$3.89 (+16.12%)Earnings
- Q2 2022 Y-mAbs Therapeutics Inc Earnings Call TranscriptAug 09, 2022$17.89 (-4.33%)Earnings
- Q1 2022 Y-mAbs Therapeutics Inc Earnings Call TranscriptMay 10, 2022$10.03 (+22.02%)Earnings
- Q4 2021 Y-mAbs Therapeutics Inc Earnings Call TranscriptFeb 25, 2022$8.91 (+11.24%)Earnings
- Y-mAbs Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2022
- Y-mAbs Therapeutics Inc Research And Development Day (Virtual) TranscriptDec 15, 2021
- Q3 2021 Y-mAbs Therapeutics Inc Earnings Call TranscriptNov 05, 2021$22.23 (-6.32%)Earnings
- Y-mAbs Therapeutics Inc to Host Key Opinion Leader Webinar on DANYELZA® - Conference Call TranscriptSep 23, 2021
- Q2 2021 Y-mAbs Therapeutics Inc Earnings Call TranscriptAug 06, 2021$29.25 (-21.60%)Earnings
- Q1 2021 Y-mAbs Therapeutics Inc Earnings Call TranscriptMay 07, 2021$34.2 (+19.37%)Earnings
- Full Year 2020 Y-mAbs Therapeutics, Inc Earnings Call TranscriptFeb 26, 2021$35.17 (+4.42%)Earnings
- Y-mAbs Therapeutics, Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2021
- Y-mAbs Therapeutics, Inc. - Special Call TranscriptDec 16, 2020
- Q3 2020 Y-mAbs Therapeutics, Inc Earnings Call TranscriptNov 06, 2020$47.32 (-2.83%)Earnings
- Y-mAbs Therapeutics, Inc. - Special Call TranscriptOct 06, 2020
- Q2 2020 Y-mAbs Therapeutics, Inc Earnings Call TranscriptAug 07, 2020$38.03 (-4.33%)Earnings
- Y-mAbs Therapeutics, Inc Annual Shareholders Meeting TranscriptJun 11, 2020
- Q1 2020 Y-mAbs Therapeutics, Inc Earnings Call TranscriptMay 08, 2020$39.84 (+12.51%)Earnings
- Q4 2019 Y-mAbs Therapeutics, Inc Earnings Call TranscriptMar 12, 2020$19.66 (-14.45%)Earnings
- Y-mAbs Therapeutics, Inc at JPMorgan Healthcare Conference TranscriptJan 16, 2020
- Y-mAbs Therapeutics, Inc. - Special Call TranscriptDec 11, 2019
- Q3 2019 Y-mAbs Therapeutics, Inc Earnings Call TranscriptNov 13, 2019$28.68 (+0.46%)Earnings
- Q2 2019 Y-mAbs Therapeutics, Inc Earnings Call TranscriptAug 14, 2019$26.16 (+1.32%)Earnings
Full Year 2020 Y-mAbs Therapeutics, Inc Earnings Call Transcript
Greetings, and welcome to Y-mAbs' Fourth Quarter and Full Year 2020 Earnings Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Thomas Gad, Chairman of Y-mAbs. Thank you, sir. You may begin.
Thank you, and thank you, everyone. Good morning, and thank you for joining us today. So 2020 was the year that we believe was truly transformational for Y-mAbs as we became a commercial stage company. We've made significant progress on executing our strategy and expanding significantly on our 3 pillars of business: first, our leading monoclonal antibodies, DANYELZA and omburtamab; second, our bispecific compounds under the Y-BICLONE tech platform; and finally, the SADA technology platform.
As you know, we received U.S. approval for DANYELZA in primary refractory and relapsed high retinoblastoma on November 25, 2020. And from the beginning of February, we
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)